Virtual Physician planned for more intimate problems

  • March 30, 2021
  • Steve Rogerson

Arizona-based biotechnology company Creative Medical Technology Holdings is launching a telehealth service this summer for patients with more intimate medical problems.

The Virtual Physician service will focus on its CaverStem regenerative stem cell procedures for treatment of erectile dysfunction in men and FemCelz regenerative stem cell procedures for vaginal rejuvenation.

As additional products are commercialised, such as the StemSpine regenerative stem cell procedure for treatment of degenerative disc disease, the platform will expand to include these products.

Furthermore, the company plans to build out Virtual Physician to include additional products outside of its proprietary procedures focused on regenerative medicine.

“While our primary interest is in supporting our providers and to educate, recruit and retain patients for our proprietary procedures through this innovative platform, we are also aware of the power of telehealth to accelerate acceptance for regenerative medicine more broadly,” said Timothy Warbington, CEO of Creative Medical Technology Holdings. “While several telehealth companies have emerged, none address this area of breakthrough medicine. As a company at the forefront of this cutting-edge industry, we see it as our responsibility to drive broad adoption.”

Virtual Physician creates three opportunities to drive shareholder value:

  • Management service organisation: Charging a fee per qualified patient to providers; conversations with existing providers validates this as valuable
  • Royalty for promotion of products from external partners: As the platform grows in popularity, companies can charge a fee from other manufacturers for featuring their products
  • Direct sales of ancillary products to consumers on platform: Become a one-stop shop for patients by curating and consolidating additional products to improve underlying medical conditions

Creative Medical Technology Holdings is a commercial stage biotechnology company specialising in regenerative medicine-stem cell technology in the fields of immunotherapy, urology, neurology and orthopaedics.